The fusion of automation and artificial intelligence (AI) is orchestrating a significant transformation in the healthcare and life sciences industries, where these technologies are optimizing operations across various domains. From clinical trials to drug development, AI and automation are not only
Epigenica AB, the Swedish HealthTech startup founded in 2020 and headquartered in Stockholm, has established itself as a leader in the burgeoning field of epigenetics. Recently garnering €1.8 million from key investors, such as Voima Ventures, Navigare Ventures, Leksell Social Ventures, and Almi
Artificial intelligence is reshaping a multitude of industries, and one of the most significant areas experiencing this transformation is drug discovery. The collaboration between Pfizer and XtalPi exemplifies the increasingly crucial role AI plays in the discovery and development of small-molecule
In a rapidly evolving healthcare landscape, few topics are as charged as the intersection of technology and medicine. James Maitland, a specialist in integrating robotics and IoT into medical applications, passionately advances healthcare solutions through cutting-edge technology. His insight
BioNTech, a leading force in the global pharmaceuticals industry, has embarked on a strategic acquisition of CureVac to solidify its position in mRNA-based cancer therapeutics. With this acquisition, the company looks to expand its capabilities beyond the notable success achieved with the COVID-19
In a groundbreaking development in the field of psychiatric care, researchers have unveiled an innovative pill designed to be taken once a week for the treatment of schizophrenia. This remarkable advancement aims to redefine the treatment landscape for patients who struggle with the debilitating
